Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation

Allogenic hematopoietic stem-cell transplant (HCT) is a curative therapy for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Relapse post-HCT is the most common cause of treatment failure and is associated with a poor prognosis. Pathologist-based visual assessment of aspirate images...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabyarmohammadi, Sara, Leo, Patrick, Viswanathan, Vidya Sankar, Janowczyk, Andrew, Corredor, German, Fu, Pingfu, Meyerson, Howard, Metheny, Leland, Madabhushi, Anant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126529/
https://www.ncbi.nlm.nih.gov/pubmed/35522898
http://dx.doi.org/10.1200/CCI.21.00156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126529/
https://www.ncbi.nlm.nih.gov/pubmed/35522898
http://dx.doi.org/10.1200/CCI.21.00156

Ejemplares similares